BOTULINUM TOXIN A PREVENTS THE DEVELOPMENT OF CONTRACTURES IN THE HEREDITARY SPASTIC MOUSE
Kaydedildi:
COSGROVE, A.P., GRAHAM, H.K., BOTULINUM TOXIN A PREVENTS THE DEVELOPMENT OF CONTRACTURES IN THE HEREDITARY SPASTIC MOUSE. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, Vol. 36, no. 5 (1994), p. 379-385.
Ref.
42955
Yer:
SIIS R.727
Palabras clave:
Discapacidad, Discapacidad física y orgánica, Espasticidad, Experimentación, Fármacos, Tratamiento
Discapacidad, Discapacidad física y orgánica, Espasticidad, Experimentación, Fármacos, Tratamiento
Benzer Materyaller: BOTULINUM TOXIN A PREVENTS THE DEVELOPMENT OF CONTRACTURES IN THE HEREDITARY SPASTIC MOUSE
- A STUDY OF THE EFFECTIVENESS OF BOTULINUM TOXIN TYPE A (DYSPORT) IN THE MANAGEMENT OF MUSCLE SPASTITICY
- THE EFFECT OF BOTULINUM TOXIN A ON GASTROCNEMIUS LENGTH: MAGNITUDE AND DURATION OF RESPONSE
- Classification of posture in poststroke upper limb spasticity: a potential decision tool for botulinum toxin A treatment?
- THE ROLE OF BOTULINUM TOXIN INJECTION IN ACHIEVING BALANCED MUSCLE FUNCTION
- BOTULINUM TOXIN A IN THE MANAGEMENT OF FOCAL MUSCLE OVERACTIVITY IN CHILDREN WITH CEREBRAL PALSY
- LONG TERM EFFICACY AND TOLERABILTIY OF 4 MONTHLY VERSUS YEARLY BOTULINUM TOXIN TYPE A TREATMENT FOR LOWER LIBM SPASTICITY IN CHILDREN WITH CEREBRAL PALSY